Plan Sponsor's Tax Credit

The Plan Sponsor's Tax Credit refers to a significant incentive provided to employers who establish and maintain retirement savings plans, such as 401(k)s, for their employees. This tax credit is designed to encourage small businesses and eligible organizations to offer retirement benefits, thereby promoting financial security for employees during their post-employment years.

In the context of employer-sponsored 401(k) plans, the Plan Sponsor's Tax Credit allows qualifying employers to claim a percentage of their plan administration expenses as a tax credit. This credit can offset a portion of the costs associated with setting up and managing the retirement plan, making it more affordable for employers to offer such benefits.

Example 1: ABC Manufacturing is a small business that decides to implement a 401(k) plan for its employees. By doing so, they become eligible for the Plan Sponsor's Tax Credit, allowing them to claim a tax credit on a percentage of the administrative expenses incurred for operating the plan.

Example 2: XYZ Nonprofit Organization wishes to attract and retain skilled employees by offering a competitive benefits package. By setting up a 401(k) plan and becoming a plan sponsor, they can benefit from the tax credit, which helps reduce the financial burden associated with administering the retirement plan.

Example 3: Smith & Co., a medium-sized company, already has a 401(k) plan in place but incurs considerable expenses to manage it. By taking advantage of the Plan Sponsor's Tax Credit, they can reduce their tax liability, freeing up funds to reinvest in their business or further enhance their employee benefits package.

Next Up

Welcome to our latest release. We are excited for you to try the new features.
According to Mployer Insights’ 2026 analysis of 50,000+ employer health plans, prescription drugs account for over 25% of total benefit expenses, with Tier 4 specialty drugs driving the majority of high-cost claims. While Tier 4 copays average $123 with coinsurance requirements in 31% of plans, individual oncology therapies like Darzalex Faspro ($170,800/yr) and Keytruda ($158,200/yr) frequently exceed average individual stop-loss deductibles ($141,938). To mitigate exposure, self-funded employers are increasingly turning to independent, transparent PBM models and biosimilar substitution—which yields up to a 73% net cost reduction per patient.
Most U.S. employers now offer paid maternity leave beyond the legal minimum, but coverage varies widely once you look past the basics. According to Mployer Insights' 2026 analysis of more than 50,000 employer benefit plans, 68% of employers provide paid maternity leave on top of short-term disability, typically adding 8 extra weeks, and half now cover 100% of salary during the disability period. Support drops off from there: only 41% of employers offer paid bonding leave for non-birth parents, and advanced family-building benefits remain even less common, with just 28% covering IVF and 11% offering adoption financial assistance. The data suggests that while baseline maternity leave has become standard, more comprehensive family-building support is still the exception rather than the norm.